期刊文献+

神经精神性狼疮30例临床分析 被引量:3

Clinical analysis of 30 cases of nervous systemic lupus erythematosus
原文传递
导出
摘要 目的:探讨系统性红斑狼疮(SLE)发生神经精神系统损害(NPLE)的临床特点和危险因素。方法回顾性分析160例 SLE 患者的临床资料,其中30例确诊 NPLE,分析 NPLE 与常见自身抗体、其他脏器损害的关系,并比较 SLE 疾病活动评分(SLEDAI)与 NPLE 的关联性。结果NPLE 患者血清中抗核抗体(ANA)、抗 Sm 抗体、抗 RNP 抗体、抗 SSA 抗体、抗 ds-DNA 抗体阳性率与无 NPLE 患者相比差异均无统计学意义(χ^2=0.947、0.013、1.194、0.023、0.745,P =0.194、0.910、0.274、0.879、0.388);肾脏损害、雷诺现象、间质性肺炎、肺血栓栓塞症、口腔溃疡、关节炎、颜面红斑、胸膜炎、心包炎、发热、肺动脉高压、光过敏、脱发在有无 NPLE 组间差异无统计学意义(χ^2=0.419、1.383、0.721、0.201、1.368、1.194、0.055、0.946、0.262、2.503、0.628、2.898、0.075,P =0.517、0.324、0.396、1.000、0.242、0.274、0.815、0.331、0.609、0.114、0.428、0.089、0.785),而手足血管炎与 NPLE 的发生明显相关(χ^2=3.996,P =0.046);NPLE 组 SLEDAI 评分为(27.63±2.26)分,明显高于无 NPLE 组的(13.83±0.25)分(t =8.446,P =0.000)。结论NPLE 的发生与常见自身抗体阳性无相关性,与其他脏器受累无关,而手足血管炎、SLEDAI 评分>15分是 NPLE 发生的危险因素。部分病例可以脑病为首发表现。及早诊断、甲泼尼龙冲击联合免疫抑制剂治疗可以有效提高疾病缓解率,减少死亡,改善预后。 Objective To invetigate clinical characteristics,pathogenesis and its risk factors of neuropsychi-atric lupus erythematosus(NPLE).Methods 160 cases of SLE patients,including 30 cases of diagnosed NPLE,were analyzed retrospectively.The relationship between the appearance of NPLE and common autoantibodies,other organ involvement and SLE disease activity score(SLEDAI)were analyzed.Results Such antibody positive rates of anti nuclear antibody(ANA),anti Sm antibody,anti -RNP antibody,anti SSA antibody,anti ds -DNA antibody had no significant difference between NPLE and non NPLE,the value of χ2 was 0.947,0.013,1.194,0.023,0.745 respectively,the value of P was 0.194,0.910,0.274,0.879,0.388 respectively.Renal involvement,raynaud phenomenon,interstitial pneumonia,pulmonary thromboembolism,oral ulcer,arthritis,facial erythema,pleuritis,pericarditis,fever,pulmonary hypertension,photo -allergy and alopecia in the two groups had no difference,the value of χ2 was respectively 0.419,1.383,0.721,0.201,1.368,1.194,0.055,0.946,0.262,2.503,0.628,2.898 and 0.075,the value of P was 0.517,0.324,0.396,1.000,0.242,0.274,0.815,0.331,0.609,0.114,0.428,0.089 and 0.785 respectively.But the occurrence of hand and foot vasculitis in NPLE was significantly higher(χ2 =3.996,P =0.046).SLEDAI of NPLE was higher than non NPLE(t =8.446,P =0.000).Conclusion There was no correlation with the occurrence of NPLE and common autoantibodies,other organ involvements.Hand and foot vasculitis and higher SLEDAI(more than 15 points)were the risk factors of NPLE.Encephalopathy may be the initial manifestation to some of SLE cases. Early diagnosis and methylprednisolone pulse treatment combined with immunosuppressive therapy can effectively improve the remission of the disease,reduce mortality and improve prognosis.
出处 《中国基层医药》 CAS 2015年第18期2819-2822,共4页 Chinese Journal of Primary Medicine and Pharmacy
关键词 红斑狼疮 系统性 狼疮脑病 危险因素 预后 Lupus erythematosus,systemic Neuropsychiatric lupus erythematosus Risk factors Prognosis
  • 相关文献

参考文献16

  • 1张琳,薛丽巾.系统性红斑狼疮伴癔病样发作一例[J].山西医药杂志(上半月),2011,40(6):630-631. 被引量:1
  • 2梅坚,张虹.狼疮脑病的临床相关因素分析(附76例报告)[J].中国社区医师(医学专业),2013,15(4):47-48. 被引量:7
  • 3刘先发,周丽程,魏桂林.36例狼疮脑病的临床分析[J].中国现代药物应用,2012,6(14):31-32. 被引量:5
  • 4Wang JG, Tang HH, Tan CY, et al. Diffuse lupus encephalopathy in a case of rhupus syndrome [ J ]. Rheumatol Int,2010,30 ( 7 ) : 961-963.
  • 5Yatin B, Kavan M, Gundre MP, et at. Posterior reversible enceph- alopathy syndrome in a patient with newly diagnosed systemic lu- pus erythematosus and thrombotic thrombocytopenic purpura[ J]. Chest Meeting,2009,136 (4) :8S.
  • 6Marrone L, Streck Ade S, Staub HL, et al. Posterior reversible en- cephalopathy syndrome ( PRES ) and systemic lupus erythemato- sus : report of two cases [ J ]. Rev Bras Reumatol, 2012,52 ( 5 ) : 804-810.
  • 7Varaprasad IR, Agrawal S, Prabu VN, et al. Posterior Reversible encephalopathy syndrome in systemic lupus erythematosus [ J ]. J Rheumatol,2011,38(8) :1607-1611.
  • 8Lai CC, Chen WS, Chang YS, et at. Clinical features and out- comes of posterior reversible encephalopathy syndrome in patients with systemic lupus erythematosus [ J ]. Arthritis Care Res, 2013, 65( 11 ) :1766-1774.
  • 9Se JP, Ki SP, Ji HK, et al. Could Increased vascular endothelial growth factor Induced by interleukin 17 be the cause of posterior reversible encephalopathy syndrome in systemic lupus erythemato- sus[J]. J Rheumatol,2012,39(4) :870.
  • 10Hu P, Lu L, Hu B,et al. Cyctophosphamide-induced hypertensive encephalopathy in a young girl with lupus[ J ]. J Clin Hypertens, 2012,14(4) :271-272.

二级参考文献33

  • 1吕鹤,张巍,袁云.中枢神经系统血管炎的研究进展[J].中国脑血管病杂志,2005,2(3):137-140. 被引量:14
  • 2Bellomio V, Spindler A, Lucero E, et al. Systemic lupus erythematosus: mortality and survival in Argentina: a muhicenter study Lupus, 2000, 9: 377-381.
  • 3Ginzler EM, Diamond HS, Weiner M, et al. A multicenter study of outcome in systemic lupus erythematosus (Part 1 ): entry variables as predictors of prognosis. Arthritis Rheum, 1982, 25: 601-611.
  • 4Abu-Shakra M, IJrowitz MB, Gladman DD, et al. Mortality study in systemic lupus erythematosus, Results from a single center. 1. Causes of death. J Rheumatol, 1995, 22: 1259-1264.
  • 5Abu-Shakra M, Gladman DD, IJrowitz MB, et al. Mortality stud- ies in SLE: how far can we improve survival of patients with SLE. Autoimmun Rev, 2004, 3: 418-420.
  • 6Cervera R, Khamashta MA, Font J, et al. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1000 patients. Medicine (Baltimore), 2003, 82: 299-308.
  • 7Trager J, Ward MM. Mortality and causes of death in systemic lupus erythematosus. Curr Opin Rheumatol, 2001, 13: 345-351.
  • 8Cervera R, Khamashta MA, Font J, et al. Morbidity and mortality in systemic lupus erythematosus during a 5-year period: a multicenter prospective study of 1000 patients. Medicine (Baltimore), 1999, 78: 167-175.
  • 9Jacobsen S, Petersen J, Ullman S, et al. Mortality and causes of deaths of 513 Danish patients with systemic lupus erythematosus, Scand J Rheumatoi, 1999, 28: 75-80.
  • 10Cook RJ, Gladman DD, Pericak D, et al. Prediction of short term mortality in systemic lupus erythematosus with time dependent measures of disease activity. J Rheumatol, 2000, 27: 1892- 1895.

共引文献82

同被引文献27

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部